Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors
- PMID: 36973349
- PMCID: PMC10169644
- DOI: 10.1038/s41375-023-01872-6
Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors
Conflict of interest statement
All authors underwent IARC clearance for potential competing interests regarding this work.
Comment on
-
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22. Leukemia. 2022. PMID: 35732829 Free PMC article. Review.
-
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22. Leukemia. 2022. PMID: 35732831 Free PMC article. Review.
-
The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH).Leukemia. 2023 Apr;37(4):946-947. doi: 10.1038/s41375-023-01821-3. Epub 2023 Jan 27. Leukemia. 2023. PMID: 36707618 No abstract available.
References
-
- Nguyen-Khac F, Bidet A, Troadec MB, Veronese L, Auger N, Daudignon A, et al. The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH). Leukemia (in press) 2023. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical